This finding indicates that despite the important functions of 14-3-3 as a regulator of CDC25, p53, FOXO, raf-1 or mTOR among others, modulation of the NF-κB pathway is the link between loss of 14-3-3σ and breast cancer patient outcome. This evidence concerns the gene TP53 and breast cancer.